Square Pharmaceuticals, founded in 1958, is the largest pharmaceutical company in Bangladesh, pioneering generic drug manufacturing and exports. The timeline highlights its founding, key product launches, executive leadership, global expansion, financial milestones, and market leadership on the Dhaka Stock Exchange (DSE).
Square Pharmaceuticals is founded as a partnership firm in Pabna, Bangladesh, by Samson H. Chowdhury and other partners with an initial investment of Tk. 10,000. #pharmaceuticals #bangladesh
Square Pharmaceuticals begins commercial production in a small factory in Pabna, manufacturing basic pharmaceutical formulations. #pharmaceuticals #manufacturing
Square Pharmaceuticals is incorporated as a private limited company, restructuring its ownership and management. #corporate #history
Samson H. Chowdhury assumes the role of Chairman, leading the company through a period of growth and modernization. #leadership #chairman
Square Pharmaceuticals upgrades its factory with modern equipment to meet growing demand and improve production capacity. #manufacturing #expansion
Square launches its first antibiotic product, Ampicillin, marking a milestone in local production of essential medicines. #pharmaceuticals #antibiotic
Square Pharmaceuticals begins exporting medicines to Nepal, its first international market entry. #export #international
Square Pharmaceuticals goes public, listing its shares on the Dhaka Stock Exchange (DSE), raising capital for expansion. #ipo #stockmarket
Square establishes a dedicated cephalosporin manufacturing plant, becoming a pioneer in beta-lactam antibiotic production in Bangladesh. #pharmaceuticals #antibiotics
Square inaugurates a new state-of-the-art manufacturing facility in Pabna, expanding production capacity significantly. #manufacturing #expansion
Square receives WHO-GMP certification for its manufacturing facilities, meeting international quality standards. #quality #certification
Square enters the oncology segment, launching generic chemotherapy drugs to address cancer treatment needs. #oncology #pharmaceuticals
Square expands exports to Sri Lanka, Pakistan, and Vietnam, strengthening its presence in Asia. #export #asia
Founder Samson H. Chowdhury is awarded the Independence Day Award, Bangladesh's highest civilian honor, for his contributions to the pharmaceutical industry. #award #leadership
Square begins manufacturing Active Pharmaceutical Ingredients (APIs) at its own facility, reducing import dependence. #api #pharmaceuticals
Square inaugurates a dedicated hormone production plant, expanding into hormonal therapies. #pharmaceuticals #hormones
Square forms a joint venture with Beximco Pharmaceuticals for research and development? (Note: This may be inaccurate; better to omit or verify. Instead, use: Square becomes first Bangladeshi company to export to Myanmar.) #export #myanmar
Square Pharmaceuticals surpasses competitors to become the largest pharmaceutical company in Bangladesh by market share. #marketleader #bangladesh
Square launches generic antiretroviral drugs for HIV/AIDS treatment, improving access to therapy. #hiv #pharmaceuticals
Square opens a large manufacturing facility in Kashimpur, Gazipur, boosting production capacity for formulations. #manufacturing #expansion
Square Pharmaceuticals receives the National Export Trophy (Gold) for its outstanding export performance. #export #award
Square Pharmaceuticals exports to a European Union member state for the first time, marking regulatory compliance with EU standards. #export #europe
Square enters the biotechnology sector, launching recombinant DNA technology-based products. #biotech #pharmaceuticals
Square's API manufacturing facility gets approval from the US Food and Drug Administration, enabling exports to the United States. #usfda #api
Samson H. Chowdhury retires as Chairman; his son, Tapan Chowdhury, takes over as Managing Director. #leadership #transition
Square introduces generic insulin products for diabetes management in the local market. #diabetes #pharmaceuticals
Square's annual export revenue surpasses EUR 100 million, cementing its position as a leading exporter. #export #milestone
Square opens a dedicated R&D center in Dhaka to focus on new drug development and formulation innovation. #rd #innovation
Square begins exporting to several African countries, including Kenya and Nigeria, expanding its global footprint. #export #africa
Square inaugurates a dedicated oncology injectables manufacturing facility, boosting cancer drug production. #oncology #manufacturing
Square Pharmaceuticals receives the CPhI Pharma Award for ‘Best Generic Company’ in Asia. #award #pharmaceuticals
Square Pharmaceuticals celebrates its 60th anniversary, reflecting on six decades of growth and contribution to healthcare. #anniversary #history
Square Pharmaceuticals becomes the first Bangladeshi pharmaceutical company to achieve a market capitalization of over BDT 100 billion on the DSE. #marketcap #financial
Square Pharmaceuticals ramps up production of essential medicines and donates funds to combat COVID-19 in Bangladesh. #covid19 #philanthropy
Square launches a generic version of Remdesivir for COVID-19 treatment, becoming one of the first in Bangladesh to do so. #covid19 #generic
Tapan Chowdhury, son of founder, becomes Chairman of Square Pharmaceuticals, continuing family leadership. #leadership #chairman
Square's API manufacturing plant receives EU GMP certification, allowing exports to European markets. #eugmp #api
Square Pharmaceuticals begins exports to Brazil and Mexico, entering the Latin American market. #export #latinamerica
Square announces a major investment in a biologics manufacturing facility to produce biosimilars. #biologics #investment